Which trials have shown no benefit from implantable cardioverter-defibrillator (ICD) therapy?

Updated: Feb 13, 2017
  • Author: Daniel M Beyerbach, MD, PhD; Chief Editor: Jeffrey N Rottman, MD  more...
  • Print


At least 4 notable, published implantable cardioverter-defibrillator (ICD) trials have failed to demonstrate a significant survival benefit to ICD therapy over optimal medical therapy. Two of these trials examined patients with ischemic cardiomyopathy and 2 examined patients with nonischemic cardiomyopathy.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!